Berwyn, Pa.-based Fresenius Vascular Care, one of its executives and several affiliates were named in the New Jersey lawsuit, and they are accused of violating the New Jersey False Claims Act as well as New York and Georgia laws.
The suit alleges that the centers scheduled end-stage renal disease patients for invasive procedures every three to four months, purportedly to preserve their dialysis access sites. Investigators said most patients had no problems receiving dialysis and the surgeries were unnecessary. The center is also accused of falsifying patient referrals, ignoring relevant medical records and falsifying diagnostic reports to justify billing for repeat procedures.
The suit also alleges that the centers pressured its providers to adopt the scheme and created incentives to maximize the number of procedures performed on dialysis patients.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
